Last Updated : December 9, 2019
CADTH is accepting nominations for two prestigious awards that recognize outstanding achievement and ongoing effort in the field of health technology assessment (HTA) in Canada. These awards are a wonderful opportunity to promote the importance of HTA in Canada and recognize those who are helping to improve our health care system by making evidence a cornerstone of health technology decisions. Completed nominations must be received by January 15, 2020. Learn more here.
In case you missed our annual drug portfolio information session and our medical device portfolio information session, you can now view the recordings here.
CADTH hosted an Evidence-to-Action event on accessing mental health support outside of a therapist’s office: Internet-based cognitive behavioural therapy for major depression and anxiety disorders. View the recording here.
CADTH recently issued the following CADTH Canadian Drug Expert Committee (CDEC) drug reimbursement recommendations:
CADTH recently issued the following CADTH pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC) drug reimbursement recommendations:
CADTH recently completed the following reports:
We love hearing how our products and services are influencing health care policies, clinical practices, and patient outcomes. If you have a success story to share, please get in touch with your CADTH Liaison Officer.
CADTH E-Alerts: Subscribe to receive the latest CADTH news, reports, feedback opportunities, and events.